OK, perhaps I stretched the analogy a bit (since price is off the recent lows), but if you look at the trend since they first went public, it reminds me of a black diamond ski slope.
Too many "investors" don't like it at any price. With the market near highs, CLF continues to lag. Trying to pick a bottom before a major move up is a risk few investors are willing to take.
Look at the long term history of this company. They've had numerous secondaries, always at a lower price. For most biotechs, the hurdle is getting FDA approval. ROSG has had products available for sale for years and yet has nothing to show for it. So lets hear your insightful analysis of how and when they will turn a profit. Exactly what is holding them back right now?
I'm sorry. I'll try to be more positive in the future. This is after all a great company with top notch management and science. The price is just a fraction of what it should be.
I was wondering why people were getting all excited about this news. I thought it might be some new investors who didn't know any better.
Once again ROSG opens higher and gives it all up as the day progresses. On the other hand, coal stocks are moving steadily higher. Hard to believe, but ROSG is worse than coal in your stocking.
Once again, those who bought in the PM are down, some over 10%. Hopefully they have learned that good news isn't that good when it comes to ROSG. When we hear about sales high enough to cover operating costs... that'll be GOOOOOOD news.
Company has a history of burning cash and not generating any significant sales. It has always had potential, but investors are tired of paying for potential.
Options volume is low, but the number of contracts offered is high. For example, the Dec 21 15 call has traded 142 contracts, 2500 are offered right now. I assume it is machine trading, but it certainly seems to hold back the share price.
Share price is up 20% in PM. Let's hope it is on more than just the NY approval of the kidney cancer test.
"Proprietary microRNA Diagnostic for Identification of the Four Most Common Kidney Tumors Now Available in All 50 U.S. States"
This is after all just one state with its own approval process. Perhaps it is like an auto manufacturer meeting CA emission regulations, i.e. if it is good enough for NY, it must be really good. Let's hope so.
Hey, even the GDX is down. Could it be that gold and the miners aren't necessarily linked? Just because you don't understand the price drivers of gold miners, do not call it manipulation.
Today's positive jobs number push interest rates higher and precious metals lower. Accordingly, TBT should go up as much as GLD goes down. So far, that isn't happening. TBT is up 0.3% and GLD is down 1.5%.
I always though gold was an inflation hedge. That hasn't been the case for quite some time.
Congratulations. You are among the very few who can say they are in the black on their ROSG investment. Ooops, wrote too soon. Last trade was 2.91.